Overview
Ensuring Gender-Affirming Health Care for Transgender and Gender-Diverse Youth
Expert Interview
Click the"View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
Transgender youth see higher rates of suicide, poorer health outcomes, and an overall lack of access to quality care. In this expert interview, join pediatrician and child psychiatrist, Jason Rafferty, MD, MPH, EdM, from the Warren Alpert Medical School of Brown University, on a path to ensuring equitable and comprehensive healthcare for transgender and gender diverse youth. Ensure your transgender and gender diverse youth patients are receiving the care they deserve.
This activity is intended for primary care physicians, pediatricians, public health professionals, physician assistants, nurse practitioners, nurses, and any other clinicians who treat or commonly encounter transgender and gender diverse youth.
The goals of this program are to increase awareness and understanding of guidelines for treating transgender and gender diverse youth. It is important that clinicians recognize disparities faced by these individuals and tailor care to support their unique needs. There is no one-size-fits-all approach for this patient population.
Upon completion of this activity, learners will be able to:
o Outline relevant terminology related to gender care
o Describe the stigma and health disparities that affect children and adolescents who are transgender or gender diverse
o Discuss strategies to ensure gender affirmative health care for transgender and gender diverse youth
o Outline relevant terminology related to gender care
o Describe the stigma and health disparities that affect children and adolescents who are transgender or gender diverse
o Discuss strategies to ensure gender affirmative health care for transgender and gender diverse youth
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
This education is brought to you by the Academy for Continued Healthcare Learning (ACHL)
Jason Rafferty, MD, MPH, EdM
Assistant Clinical Professor
Warren Alpert Medical School of Brown University
Pediatrician & Child Psychiatrist, Thundermist Health Centers Pediatrician & Child Psychiatrist, Emma Pendleton Bradley Hospital
Chair, Executive Committee of the Section on LGBTQ Health and Wellness
American Academy of Pediatrics
Providence, RI
Assistant Clinical Professor
Warren Alpert Medical School of Brown University
Pediatrician & Child Psychiatrist, Thundermist Health Centers Pediatrician & Child Psychiatrist, Emma Pendleton Bradley Hospital
Chair, Executive Committee of the Section on LGBTQ Health and Wellness
American Academy of Pediatrics
Providence, RI
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
The following financial relationships have been provided:
Jason Rafferty, MD, MPH, EdM, (Faculty)
No financial relationships to disclose
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: puberty blockers and hormone therapy for gender-affirming care in children and adolescents.
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of any ineligible companies. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 30 minutes to complete. To receive credit, learners are required to view the activity and complete the evaluation. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Michelle Forcier at mforcier@achlcme.org
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.